Wei, G., Dong, L., Yang, J., Zhang, L., Xu, J., Yang, F., Cheng, R., Xu, R., & Chen, S. (2018), “Integrated Metabolomic And Transcriptomic Analyses Revealed The

45. Kang N.J., Jung S.K., Lee K.W., Lee H.J (2011), “Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis”, Ann N Y Acad Sci, 1229, pp. 124–132.

46. García E.R., Gutierrez E.A., de Melo F.C.S.A., Novaes R.D., Gonçalves R.V. (2018), “Flavonoids effects on hepatocellular carcinoma in murine models: A systematic review”, Evid Based Complement Altern Med, 2018, pp. 6328970.

47. Vetvicka V, Teplyakova TV, Shintyapina AB, Korolenko TA (2021), “Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression”, Journal of Fungi, 7(4), pp. 250.

48. Ina, K., Kataoka, T., & Ando, T. (2013), “The use of lentinan for treating gastric cancer”, Anti-cancer agents in medicinal chemistry, 13(5), pp. 681–688.

49. Li, X., He, Y., Zeng, P., Liu, Y., Zhang, M., Hao, C., Wang, H., Lv, Z., & Zhang, L. (2019), “Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China”, Journal of cellular and molecular medicine, 23(1), pp. 4–20.

50. Luo, H., Vong, C. T., Chen, H., Gao, Y., Lyu, P., Qiu, L., Zhao, M., Liu, Q., Cheng, Z., Zou, J., Yao, P., Gao, C., Wei, J., Ung, C., Wang, S., Zhong, Z., & Wang, Y. (2019), “Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine”, Chinese medicine, 14, pp. 48.

51. Liu, W., Yang, B., Yang, L., Kaur, J., Jessop, C., Fadhil, R., Good, D., Ni, G., Liu, X., Mosaiab, T., Yi, Z., & Wei, M. Q. (2019), “Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers”, Evidence-based complementary and alternative medicine, 2019, pp. 6057837.

52. Pérez, L. B., Still, P. C., Naman, C. B., Ren, Y., Pan, L., Chai, H. B., Carcache de Blanco, E. J., Ninh, T. N., Van Thanh, B., Swanson, S. M., Soejarto, D. D., & Kinghorn, A. D. (2014), “Investigation of Vietnamese plants for potential anticancer agents”, Phytochemistry reviews: proceedings of the Phytochemical Society of Europe, 13(4), pp. 727–739.

53. Vũ Thị Nguyệt, Nguyễn Tiến Đạt, Lê Mai Hương, Trần Thị Hồng Hà, Nguyễn Hồng Chuyên, Nguyễn Thị Hằng, Đặng Đình Kim (2018), “Đánh giá hoạt tính gây độc tế bào ung thư của các chất chiết xuất từ thân cây xạ đen (Ehretia asperula Zoll. & Mor)”, Tạp chí Sinh học, 40(2), tr. 145-152.

54. Trần Thị Hải Vân, Nguyễn Quỳnh Anh, Đỗ Hòa Bình, Phan Anh Tuấn (2013), “Tác dụng kháng ung thư của cốm sói rừng trên chuột mang u sarcoma 180”, Tạp chí Y dược học cổ truyền Việt Nam, 38, tr. 9-15.

Có thể bạn quan tâm!

Xem toàn bộ 222 trang tài liệu này.

55. Trần Mạnh Hùng, Nguyễn Hải Đăng, Trần Phương Thảo, Trần Phi Long, Jeong Hyung Lee, Lê Phước Cường, Phạm Thanh Huyền, Phương Thiện Thương (2018), “Bước đầu nghiên cứu hoạt tính gây độc tế bào ung thư tụy của lanostan triterpenoid từ lá cây na rừng”, Tạp chí Dược liệu, tập 23(4), tr. 210 - 216.

56. Bộ môn Dược liệu (2004), Bài giảng dược liệu, Tập 1, Bộ môn Dược liệu trường Đại học Dược Hà Nội, tr. 172-177.

Nghiên cứu tác dụng kháng u thực nghiệm của rễ củ Tam thất Panax notoginseng Burk. F.H. Chen, Araliaceae trồng ở Việt Nam trước và sau chế biến - 24

57. Đỗ Huy Bích và cộng sự (2006), Cây thuốc và động vật làm thuốc ở Việt Nam, tập 1, 2, Nhà xuất bản Khoa học và Kỹ thuật, tr. 775-780.

58. Qu, J., Xu, N., Zhang, J., Geng, X., & Zhang, R. (2020), “Panax notoginseng saponins and their applications in nervous system disorders: a narrative review”, Annals of translational medicine, 8(22), pp. 1525.

59. Wei, G., Dong, L., Yang, J., Zhang, L., Xu, J., Yang, F., Cheng, R., Xu, R., & Chen, S. (2018), “Integrated metabolomic and transcriptomic analyses revealed the

distribution of saponins in Panax notoginseng”, Acta pharmaceutica Sinica, 8(3), pp. 458–465.

60. Wang, Zheng & Chen, Yuan-yuan & Pan, Hui-jie & Wei, Li & Wang, You-hua & Zeng, Chen-hong (2015), “Saponin Accumulation in Flower Buds of Panax notoginseng”, Chinese Herbal Medicines, 7(2), pp. 179-184.

61. Wang, D., Zhu, H., Chen, K., Xu, M., Zhang, Y., & Yang, C. (2011), “Saponin accumulation in the seedling root of Panax notoginseng”, Chinese medicine, 6(1), pp. 5.

62. Zhang H-z, Liu D-h, Zhang D-k, Wang Y-h, Li G, Yan G-l, et al. (2016), “Quality Assessment of Panax notoginseng from Different Regions through the Analysis of Marker Chemicals, Biological Potency and Ecological Factors”, PLoS ONE, 11(10), pp. e0164384.

63. Toh DF, New LS, Koh HL, Chan EC. (2010), “Ultra-high performance liquid chromatography/time-of-flight mass spectrometry (UHPLC/TOFMS) for time- dependent profiling of raw and steamed Panax notoginseng”, J Pharm Biomed Anal, 52(1), pp. 43–50.

64. Chen B, Cai T, Jia XB. (2014), “Simultaneous determination of ten active ginsenosides in steamed notoginseng by UPLC”, China J Chinese Materia Med, 39, pp. 1614–1619.

65. Wu S, Guo CL, Cui XM, Yang XY. (2015), “Simultaneous determination of ten kinds of saponins in raw and steamed Panax notoginseng root and rhizome by HPLC”, J Chin Med Mater, 38, pp. 1622–1625.

66. Wang, J.-R., Yau, L.-F., Gao, W.-N., Liu, Y., Yick, P.-W., Liu, L., et al. (2014), “Quantitative Comparison and Metabolite Profiling of Saponins in Different Parts of the Root of Panax Notoginseng”, J Agric Food Chem, 62, pp. 9024–9034.

67. Lee, C.-Y., Hsieh, S.-L., Hsieh, S., Tsai, C.-C., Hsieh, L.-C., Kuo, Y.-H., et al. (2017), “Inhibition of Human Colorectal Cancer Metastasis by Notoginsenoside R1, an Important Compound from Panax Notoginseng”, Oncol Rep, 37, pp. 399– 407.

68. Thu Dang Kim, Hai Nguyen Thanh, Duong Nguyen Thuy, Loi Vu Duc, Thu Vu Thi, Hung Vu Manh, Patcharee Boonsiri, Tung Bui Thanh (2016), “Anticancer effects of saponin and saponin–phospholipid complex of Panax notoginseng grown in Vietnam”, Asian Pacific Journal of Tropical Biomedicine, 6(9), pp. 795-800.

69. Ohtani K., Mizutani K., Hatono S., Kasai R., Sumino R., Shiota T., Ushijima M., Zhou J., Fuwa T., Tanaka O. (1987), “Sanchinan-A, a reticuloendothelial system activating arabinogalactan from sanchi-ginseng (roots of Panax notoginseng)”, Planta Medica, 53(2), pp. 166-169.

70. Li X. Y. (1991), “Immunomodulating Chinese herbal medicines”, Memorias do Instituto Oswaldo Cruz, 86(2), pp. 159-164.

71. Gao H., Wang F., Lien E. J., Trousdale M. D. (1996), “Immunostimulating polysaccharides from Panax notoginseng”, Pharmaceutical Research, 13(8), pp. 1196-200.

72. Sun H. X., Pan H. J., Pan Y. J. (2003), “Haemolytic activities and immunologic adjuvant effect of Panax notoginseng saponins”, Acta pharmacologica Sinica, 24(11), pp. 1150-1154.

73. Choi, J. G., Jin, Y. H., Lee, H., Oh, T. W., Yim, N. H., Cho, W. K., & Ma, J. Y. (2017), “Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity”, Frontiers in immunology, 8, pp. 1542.

74. Kim, B., Kim, E. Y., Lee, E. J., Han, J. H., Kwak, C. H., Jung, Y. S., Lee, S. O., Chung, T. W., & Ha, K. T. (2018), “Panax notoginseng Inhibits Tumor Growth

through Activating Macrophage to M1 Polarization”, The American journal of Chinese medicine, 46(6), pp. 1369–1385.

75. Zhang, Y., Qiu, Z., Qiu, Y., Su, T., Qu, P., & Jia, A. (2019), “Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment”, Integrative cancer therapies, 18, pp. 1-9.

76. Zhang, Z., Zhang, Y., Gao, M., Cui, X., Yang, Y., van Duijn, B., Wang, M., Hu, Y., Wang, C., & Xiong, Y. (2020), “Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway”, Frontiers in pharmacology, 10, pp. 1578.

77. Wu R, Ru Q, Chen L, Ma B, Li C. (2014), “Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice”, J Food Sci, 79(7), pp. 1430–1435.

78. Wei B, Duan Z, Zhu C, Deng J, Fan D. (2018), “Anti-anemia effects of ginsenoside Rk3 and ginsenoside Rh4 on mice with ribavirin-induced anemia”, Food Funct, 9(4), pp. 2447–2455.

79. Guang-Rong Zhao, Zhi-Jun Xiang, Ting-Xiang Ye, Ying-Jin Yuan, Zhi-Xin Guo (2006), “Antioxidant activities of Salvia miltiorrhiza and Panax notoginseng”, Food Chemistry, 99(4), pp. 767-774.

80. He, N. W., Zhao, Y., Guo, L., Shang, J., & Yang, X. B. (2012), “Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen”, Journal of medicinal food, 15(4), pp. 350–359.

81. Xiong, Y., Chen, L., Man, J., Hu, Y., & Cui, X. (2019), “Chemical and bioactive comparison of Panax notoginseng root and rhizome in raw and steamed forms”, Journal of ginseng research, 43(3), pp. 385–393.

82. Xiong Y, Chen L, Hu Y and Cui X (2017), “Uncovering Active Constituents Responsible for Different Activities of Raw and Steamed Panax notoginseng Roots”, Front Pharmacol, 8, pp. 745.

83. You, S., Shi, X., Yu, D., Zhao, D., An, Q., Wang, D., Zhang, J., Li, M., & Wang, C. (2021), “Fermentation of Panax notoginseng root extract polysaccharides attenuates oxidative stress and promotes type I procollagen synthesis in human dermal fibroblast cells”, BMC complementary medicine and therapies, 21(1), pp. 34.

84. Zhou, L., Huang, P. P., Chen, L. L., & Wang, P. (2019), “Panax Notoginseng Saponins Ameliorate Aβ-Mediated Neurotoxicity in C. elegans through Antioxidant Activities”, Evidence-based complementary and alternative medicine, 2019, pp. 7621043.

85. Du, Y. G., Wang, L. P., Qian, J. W., Zhang, K. N., & Chai, K. F. (2016), “Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats”, Chinese journal of integrative medicine, 22(12), pp. 910–917.

86. Chan, Paul & Pai Feng, Kao & Tomlinson, Brian. (2005), “Cardiovascular Effects of Trilinolein, a Natural Triglyceride Isolated from the Herb Sanchi (Panax Notoginseng)”, Acta Cardiologica Sinica, 21, pp. 71-76.

87. Hu S, Wu Y, Zhao B, Hu H, Zhu B, Sun Z, Li P, Du S. (2018), “Panax notoginseng Saponins Protect Cerebral Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Reperfusion-Induced Barrier Dysfunction via Activation of PI3K/Akt/Nrf2 Antioxidant Signaling Pathway”, Molecules, 23(11), pp. 2781.

88. Ding, R. B., Tian, K., Cao, Y. W., Bao, J. L., Wang, M., He, C., Hu, Y., Su, H., & Wan, J. B. (2015), “Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid

accumulation and reducing ethanol-mediated oxidative stress”, Journal of agricultural and food chemistry, 63(9), pp. 2413–2422.

89. Sanchez-Valle V., Chavez-Tapia N.C., Uribe M., Mendez-Sanchez N (2012), “Role of oxidative stress and molecular changes in liver fibrosis: A review”, Curr Med Chem, 19, pp. 4850–4860.

90. Sakaguchi S., Takahashi S., Sasaki T., Kumagai T., Nagata K (2011), “Progression of alcoholic and non-alcoholic steatohepatitis: Common metabolic aspects of innate immune system and oxidative stress”, Drug Metab Pharmacokinet, 2011(26), pp. 30–46.

91. Cichoz-Lach H., Michalak A (2014), “Oxidative stress as a crucial factor in liver diseases”, World J Gastroenterol, 20, pp. 8082–8091.

92. Wu D., Cederbaum A.I (2009), “Oxidative stress and alcoholic liver disease”,

Semin Liver Dis, 29, pp. 141–154.

93. Lin, C. F., Wong, K. L., Wu, R. S., Huang, T. C., & Liu, C. F. (2003), “Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity”, Phytotherapy research : PTR, 17(9), pp. 1119–1122.

94. Dương Thị Ly Hương, Nguyễn Trần Giáng Hương, Phạm Xuân Sinh (2004), “Tác dụng hồi phục các tổn thương gan gây ra bởi CCl4 của củ tam thất trên chuột thực nghiệm”, Tạp chí Dược học, tập 334, tr. 38-41.

95. Prasain, J. K., Kadota, S., Basnet, P., Hase, K., & Namba, T. (1996), “Hepatoprotective effects of Panax notoginseng: Ginsenosides -Re and -Rg(1) as its active constituents in D-galactosamine/lipopolysaccharide-induced liver injury”, Phytomedicine : international journal of phytotherapy and phytopharmacology, 2(4), pp. 297–303.

96. Wang, C., Zheng, L., Liu, S., Guo, X., Qu, Y., Gao, M., Cui, X., & Yang, Y. (2020), “A novel acidic polysaccharide from the residue of Panax notoginseng and

its hepatoprotective effect on alcoholic liver damage in mice”, International journal of biological macromolecules, 149, pp. 1084–1097.

97. Qu, L., Fu, R., Ma, X., & Fan, D. (2021), “Hepatoprotective effects of ginsenoside Rk3 in acetaminophen-induced liver injury in mice by activation of autophagy”, Food & function, 12(19), pp. 9128–9140.

98. Zhong, H., Wu, H., Bai, H., Wang, M., Wen, J., Gong, J., Miao, M., & Yuan, F. (2019), “Panax notoginseng saponins promote liver regeneration through activation of the PI3K/AKT/mTOR cell proliferation pathway and upregulation of the AKT/Bad cell survival pathway in mice”, BMC complementary and alternative medicine, 19(1), pp. 122.

99. Bui Thanh Tung, Nguyen Thanh Hai, Vu Thi Thom, Nguyen Huu Tung, Vu Duc Loi, Vu Manh Hung, Bui Thi Thu Ha (2016), “Phytochemical and Antithrombotic Effect of Panax notoginseng Grown in Viet Nam”, Current Traditional Medicine, 2(1), pp. 50-58.

100. Xu, Z. Y., Xu, Y., Xie, X. F., Tian, Y., Sui, J. H., Sun, Y., Lin, D. S., Gao, X., Peng, C., & Fan, Y. J. (2021), “Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy”, Chinese medicine, 16(1), pp. 12.

101. Zejun Zhang, Lijuan Chen, Xiu-ming Cui, Yiming Zhang, Yupiao Hu, Chengxiao Wang and Yin Xiong (2019), “Identification of anti-inflammatory components of raw and steamed Panax notoginseng root by analyses of spectrum- effect relationship”, RSC Advances, 2019(9), pp. 17950-17958.

102. Uzayisenga, R., Ayeka, P. A., & Wang, Y. (2014), “Anti-diabetic potential of Panax notoginseng saponins (PNS): a review”, Phytotherapy research : PTR, 28(4), pp. 510–516.

103. Joo, I. W., Ryu, J. H., & Oh, H. J. (2010), “The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with

..... Xem trang tiếp theo?
⇦ Trang trước - Trang tiếp theo ⇨

Ngày đăng: 20/03/2024